Maximizing outcomes in the treatment of radial head fractures

Swensen, Stephanie J.; Tyagi, Vineet; Uquillas, Carlos; Shakked, Rachel J.; Yoon, Richard S.; Liporace, Frank A.

doi:10.1186/s10195-019-0523-5

Journal of Orthopaedics and Traumatology

Official Journal of the Italian Society of Orthopaedics and Traumatology

Table 1 Summary of studies

From: Maximizing outcomes in the treatment of radial head fractures

Study	N total	Level of evidence	Outcome measure	Outcome score average	Follow-up (mean)	Mason type	Complications
Ring et al. [38]	56	Prognostic II	SBM	92	48	II-38 III-26	Nonunion
Iacobellis et al. [17]	32	Prognostic II	DASH MEPS	Type II-6.8 Type III-9.5 Type II-98.4 Type III-99.3	47	II-25 III-7	Heterotopic ossification (type II-1, III-3)
Nalbantoglu et al. [33]	25	Prognostic II	SBM	Type III-88 Type III w/dislocation-87	27	III-25	Heterotopic ossification (type III w/dislocation-3)
Ikeda et al. [20]	10	Prognostic II	SBM	90.7	28.5	III-3 IV-7	None
Lindenhovius et al. [27]	13	Therapeutic III	ASES MEPS SBM	91 92 91	17 years	II-5 III-8	Early hardware loosening
Ruan et al. [41]	8	Therapeutic III	SBM	12.5% satisfactory	14	III-8	Heterotopic ossification, nonunion and bone absorption
Ikeda et al. [19]	13	Therapeutic III	SBM ASES	90.7 94.6	36	III-3 IV-10	None
Zarattini et al. [52]	35	Therapeutic III	SBM DASH	95.09 2.81	125	II-35	Intraarticular screw placement-1
Chen et al. [7]	23	Therapeutic I	SBM	72.4, 65.2% satisfactory	2.8 years	III-23	Heterotopic ossification-2 Deep wound infection-1 ROM deficit > 30 deg-2
Businger et al. [6]	6	Therapeutic III	SBM MEPI DASH PCS-12 MCS-12	97 99.2 1.94 52.2 59.5	112	III-2 IV-4	Persistent pain requiring resection- 1
Lindenhovius et al. [28]	16	Therapeutic III	SBM MEPI ASES DASH	91 89 93 12	22 years	II-16	Deep infection-1 Superficial infection-1 Transient PIN palsy-1 Restricted forearm ROM-2 Persistent pain-1
Moro et al. [30]	24	Prognostic II	SF-36 DASH MEPI	47 17 80	39	III- 10 IV- 15	None
Grewal et al. [11]	26	Therapeutic IV	SF-36 Physical Mental DASH MEPI ASES Pain Function Satisfaction PREE	41.8 51.5 24.4 80.5 13.4 27.5 9.0 22.9	24.5		Heterotopic ossification Stage I-4 Stage II-1 Stage IV-1
Ruan et al. [41]	14	Therapeutic III	SBM	92.9% satisfactory	15.9	III-14	Heterotopic ossification-3
Chen et al. [7]	22	Therapeutic I	SBM	92.1, 91% satisfactory	2.8 years	III-22	ROM deficit > 30 deg-2 Stiffness caused by prosthesis-1
Iftimie et al. [18]	27	Therapeutic IV	MEPS DASH VAS	96.4 4.89 0.48	16.9 years	II-5 III-16 IV-6	None
Ricon et al. [35]	28	Therapeutic IV	MEPS	92	32	III-28	Ulnar nerve neuropathy-1 Radiocapitellar incongruence-1 Device removal-3
Burkhart et al. [5]	17	Therapeutic IV	MEPS DASH	90.83 9.8	106		Prosthetic dislocation-2 Capitellar erosion- 3
Popovic et al. [34]	11	Therapeutic III	SBM	82	32	III-11	Heterotopic ossification Class IIA-1
Harrington et al. [14]	20	Therapeutic IV	SBM	88	12.1 years	II-1 IV-13	Persistent pain- 4 Heterotopic ossification Stage I-3 Stage II-2 Stage III-3
Dotzis et al. [9]	14	Therapeutic IV	MEPS DASH		63	III-6 IV 8	Severe complex regional pain syndrome

ASES American Shoulder and Elbow Surgeons Shoulder Score, DASH Disability of Arm Shoulder Hand, MCS-12 Mental Component Summary, MEPS Mayo Elbow Performance Score, MEPI Mayo Elbow Performance Index, PCS-12 Physical Component Summary, PREE Patient Rated Elbow Evaluation, SMB Broberg and Morrey functional rating score, SF-36 Short Form-36, VAS Visual Analog Scale
Mason type is based on original Mason classification [11]

Back to article page